Protocol No.: S2427

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Principal Investigator
Fareed, Muhammad
Phase
II (Cancer Control)
Age Group
Adult
Applicable Disease Site
Genitourinary Cancers
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
Contacts
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Patricia Policicchio
Research Specialist

View on ClinicalTrials.gov